metoclopramide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tandon, M | 1 |
Coudriet, GM | 1 |
Criscimanna, A | 1 |
Socorro, M | 1 |
Eliliwi, M | 1 |
Singhi, AD | 1 |
Cruz-Monserrate, Z | 1 |
Bailey, P | 1 |
Lotze, MT | 1 |
Zeh, H | 1 |
Hu, J | 1 |
Goffin, V | 1 |
Gittes, GK | 1 |
Biankin, AV | 1 |
Esni, F | 1 |
1 other study available for metoclopramide and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Collagen; Disease Progression; Epithelium; | 2019 |